1. Shan Shao, Xiaoai Zhao, Shanzhi Gu* and Xinhan Zhao*; Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.Molecular Cancer,2015,14:28. SCI收录(IF=5.397)
2. Xiaojin Zhang, Xiaoai Zhao, Shanzhi Gu* and Xinhan Zhao*; Notch1 induces epithelial--mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.International Journal of Oncology,2015, 46:1141-1148. SCI收录(IF=2.773)
3. Meng M, Zhao X*, Dang Y, et al. Region-specific expression of brain-derived neurotrophic factor splice variants in morphine conditioned place preference in mice[J]. Brain Research,2013,1519(0):53-62 SCI 收录(IF=2.879)
4. Hou L, Zhao XH*, Wang P, Ning Q, Meng M: Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells. PLOS ONE 2013; 8(1): e53491. Epub 2013 Jan 11. SCI收录(IF=4.092)
5. Ning Q, Zhao XH*, Liu C, Hou L, et al. Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition[J]. PLoS One,2013,8(6):e65217.)
6. Xin G, Zhao X*, Duan X, Ning Q, Meng M, Meng D, Liu L: Antitumor effect of a generation 4 polyamidoamine dendrimer/cyclooxygenase-2 antisense oligodeoxynucleotide complex on breast cancer in vitro and in vivo. Cancer Biother Radiopharm 2012, 27(1):77-87. SCI收录(IF=1.873)
7. Ning Q, Hou L, Meng M, Pan BR, Zhao XH*. TNF related apoptosis -inducing ligand and its receptors in ocular tumors. Int J Ophthalmol 2011, 4(5):552-557. SCI-E收录
8. Wang P, Zhao XH*, Wang ZY, Meng M, Li X, Ning Q: Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment. Cancer Lett 2010, 298(1):34-49. SCI收录(IF=5.016)
9. Meng M, Zhao XH*, Ning Q, Hou L, Xin GH, Liu LF:Tumor stem cells: A new approach for tumor therapy. Oncology Letters 2012;4(2): 187–193 SCI收录(IF=0.987) 10. Xin GH, Zhao XH*,Liu D, Gong Q, Hou L, Li JY, Pan BR, Li X and Cheng YJ: Effect of VEGF-targeted antisense gene therapy on retinoblastoma cell line SO-RB50 in vitro and in vivo. Int J Ophthalmol 2012;5(4): 440–447.(SCIE收录)
11. Na Yuan, Min Meng, Caigang Liu, Shanzhi Gu, Xinhan Zhao*:Clinical characteristics and prognostic analysis of triple‑negative breast cancer patients.Molecular and Clinical Oncology 2014,245-251( MI收录)
12. Qin TJ, Ma W, Liu SX, Yang GX, Wang QY, Zhao XH*: Secretory expression of Par-4 SAC-HA2TAT following adeno-associated virus-mediated gene transfer induces apoptosis in HepG2 cells. Mol Med Report 2010, 3(5):749-757. SCI收录(IF=0.307)
16. Zhao X, Li L, Wang Z: Chemoprevention of breast cancer: current status and future prospects. Front Biosci 2006, 11:2249-2256. SCI收录(IF=2.623) 17. Zhao X, Tian H, Ma X, Li L: Epigallocatechin gallate, the main ingredient of green tea induces apoptosis in breast cancer cells. Front Biosci 2006, 11:2428-2433. SCI收录(IF=2.623) 19. Zhao XH, Gu SZ, Tian HG, Quan P, Pan BR: Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue. World J Gastroenterol 2005, 11(25):3846-3849. MI收录 20. Zhao XH, Gu SZ, Liu SX, Pan BR: Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World J Gastroenterol 2003, 9(4):665-669. SCI收录(IF=3.318) 21. Caigang Liu, Xinhan Zhao, Zuowei Zhao, et al: Malignant Inflammatory Myofibroblastic Tumor of the Prostate. Journal of Clinical Oncology 2013, 31(10):e144-147. SCI收录(IF=18.038)
22. Ling Chen, YaRong Wang, Le Zhao, Wei Chen, Chunhui Dong, Xinhan Zhao, Xu Li: Hsp 74, a Poteintial Bladder Cancer Marker, Has Direct Interaction with Keratin 1. Journal of Immunology Research 2014 :492849. SCI收录(IF=3.064)
23. Xiaoxiao Zuo, Yan Qin, Xiaojin Zhang, Xinhan Zhao*:Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. Oncology Reports. 31: 2358-2364, 2014 SCI收录(IF=2.297)
收录(IF=2.29724. Lifeng Liu, Lei Hou, Shanzhi Gu, Xiaoxiao Zuo, Du Meng, Minna Luo, Xiaojin Zhang, Shangke Huang and Xinhan Zhao,Molecular mechanism of pigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo. Oncology Reports. 33: 297-303, 2015 SCI)
25. Du Meng, Rui Liu, Li Pei, and Xinhan Zhao*:Lentivirus Vector-mediated Gene Transfection of CNGRC Peptide in Rat Adipose Stem Cells. 2014 Oncology Reports.(SCI, online)(IF=2.297)
26. Yaning Zhao, Na Yuan, Xinhan Zhao: Bilateral Breast Cancer Following Augmentation Mammaplasty with Polyacrylamide Hydrogel Injection: A case report. Oncology Letters 2014 (SCI, Accepted) (IF=0.987)
27. Xiaoxiao Zuo, Ling Chen, Lifeng Liu, Zhe Zhang, Xiaojin Zhang, Qing Yu, Lu Feng, Xinhan Zhao* and Tianjie Qin. Identification of a panel of complex autoantigens(LGALS3, PHB2, MUC1 and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer. Tumor Biology.2014(SCI, Accepted)(IF=2.84)
28. 袁娜,辛国宏,左笑笑,黄尚科,王莹,侯磊,秦天洁,赵新汉*.联合应用噬菌体展示技术与重组cDNA表达文库血清学分析技术筛选肺癌早期诊断相关抗原[J].浙江大学学报(医学版)MEDLINE收录,2014:129-137.
29. 罗秦英,罗敏娜,唐露,魏友霞,赵新汉*. 伊立替康联合卡培他滨治疗转移性结直肠癌的临床研究[J]. 中华临床医师杂志(电子版),2013.
30. 罗秦英,罗敏娜,唐露,魏友霞,赵新汉*.奥沙利铂或伊立替康联合卡培他滨治疗转移性结直肠癌的临床研究[J]. 中华临床医师杂志(电子版),2013.
31. 王新帅,赵新汉,冯笑山,赵永刚,郭艳珍. CEA,CA-199在FOLFOX4方案治疗中晚期结直肠癌中的意义[J].陕西医学杂志2010,39(11):1475-1480.
32. 王新帅,赵永刚,冯笑山,赵新汉,祁岩超,郭艳珍.负载U251抗原树突状细胞增强CIK杀伤作用的实验研究[J].中华神经医学杂志2009,8(7).
33. 赵征,赵新汉 ,袁勇,王晓敏,俱惠英乳腺癌MMP9与C-erbB-2表达相关性研究[J].现代肿瘤医学2010,18(6):1116-1117.
34. 赵征,赵新汉,袁勇,王晓敏,王一凡乳腺癌基质金属蛋白酶9表达与临床病理因素相关性研究[J].现代肿瘤医学2009,17(5):867-869.
35. 赵征,廖子君,. 生脉注射液配合老年晚期胃癌化疗的临床观察[J].现代肿瘤医学2005,13(3):387-388. 赵新汉
36. 赵征,,袁勇乳腺癌中C-erbB-2的表达与临床病理因素相关性研究[J]。现代肿瘤医学2006,14(10):1231-1232. . 赵新汉
41. 赵新汉, 王志宇, 李琳琳, 李丽, 李晓花. 三苯氧胺诱导乳腺癌细胞凋亡过程中ERα和SMRT的表达变化. 浙江大学学报(医学版) 2008(03):276-282. 42. 赵新汉, 李丽, 王志宇, 张灵小, 安改丽. G4PAMAM/VEGFASODN抗乳腺癌血管生成的体外实验研究. 浙江大学学报(医学版) MEDLINE收录2008(06):612-621. 43. 赵新汉, 田方. 肿瘤血管生成抑制剂的研究现状与展望. 现代肿瘤医学 2008(11):2004-2006. 44. 赵新汉, 田方, 王志宇. 肿瘤基因治疗载体的研究现状和展望. 现代肿瘤医学 2007(12):1879-1882. 46. 赵新汉, 全平, 李晶, 田洪刚, 刘陕西. 雄黄诱导白血病细胞凋亡的研究. 现代肿瘤医学 2006(01):88-90. 47. 赵新汉, 王志宇, 李晶, 李丽. 槲皮素诱导人白血病细胞K562的凋亡. 第四军医大学学报 2006, 27(15):1395-1398. 48. 赵新汉, 李晶, 李琳琳, 马欣, 田洪刚, 刘陕西. Bcl-2参与的抗凋亡机制在白血病耐药中的作用. 第四军医大学学报 2005, 26(23):2192-2194. 49. 赵新汉, 田洪刚, 全平, 刘陕西. 促凋亡蛋白Caspase-3与白血病细胞耐药的相关性. 西安交通大学学报(医学版) 2005, 26(5):463-466, 469. 50. 赵新汉, 马欣, 李琳琳, 李晶, 刘陕西. Caspase-3和Bcl-2在白血病细胞株凋亡过程中的表达及其与多药耐药的关系. 西安交通大学学报(医学版) 2005, 26(6):581-585. 51. 赵新汉, 田洪刚. 肿瘤的分子靶向治疗. 现代肿瘤医学 2005, 13(1):133-136. 52. 赵新汉, 马欣. 晚期结直肠癌时间化疗研究进展. 现代肿瘤医学 2005, 13(4):附4-附5. 53. 赵新汉, 马欣, 田洪刚. 进展期胃癌根治性术后腹腔内化疗的疗效评价(英文). 现代肿瘤医学 2005(06):76-79. 54. 赵新汉, 秦天洁, 肖菊香, 周小娟, 刘陕西. 进展期胃癌患者化学-内分泌治疗的临床评价. 西安交通大学学报(医学版) 2003, 24(6):608-610. 55. 赵新汉 , 顾珊智, 刘陕西, 李蓉. 恶性肿瘤多药耐药的基础与临床研究.
中国肿瘤 2003, 12(1):34-36.